Index Ventures leads E34m financing round for Cellzome

The biopharmaceutical company will use the funding to boost infrastructure, programmes and recruit staff.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this